Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.
Retina Foundation of the Southwest, Dallas, Texas, USA.
Am J Ophthalmol. 2019 Dec;208:124-132. doi: 10.1016/j.ajo.2019.07.018. Epub 2019 Aug 1.
To evaluate the recently developed Pediatric Eye Questionnaire (PedEyeQ) in visually impaired and visually normal children, as an initial validation of the PedEyeQ.
Questionnaire validation study.
A total of 48 children with visual impairment (retinal, cortical, and corneal conditions) and 59 visually normal controls were enrolled at 2 centers. Five- to 17-year-old children completed the Child PedEyeQ (5-11- and 12-17-year-old versions), and parents completed the Proxy PedEyeQ (0-4-, 5-11-, and 12-17-year-old versions) and the Parent PedEyeQ. Rasch scores were calculated by age group for each distinct domain within each age-specific PedEyeQ (converted to 0-100 for interpretation). Domains for the Child PedEyeQ are functional vision, bothered by eyes/vision, social, and frustration/worry. Proxy PedEyeQ domains are functional vision, bothered by eyes/vision, social, frustration/worry, and eye care. Parent PedEyeQ domains are impact on parent and family, worry about child's eye condition, worry about child's self-perception/interactions, and worry about child's functional vision. For each domain, median PedEyeQ scores were compared between visually impaired and visually normal cohorts.
Child 5-11 and 12-17 PedEyeQ scores were significantly lower (worse) for visually impaired children than for controls for each domain (P < .007), except for the social domain in 5-11-year-old children (P = .13). In addition, Proxy 0-4-, 5-11-, and 12-17-year-old PedEyeQ scores, and Parent PedEyeQ scores, were lower for visually impaired children across all domains (P < .001).
Visually impaired children and their parents had significantly lower (worse) PedEyeQ scores than visually normal controls, across functional vision and eye-related quality of life domains, demonstrating known-group validity of the PedEyeQ in children with visual impairment.
评估最近开发的小儿眼病问卷(PedEyeQ)在视力障碍和视力正常儿童中的应用,作为对 PedEyeQ 的初步验证。
问卷验证研究。
在 2 个中心共招募了 48 名视力障碍(视网膜、皮质和角膜疾病)儿童和 59 名视力正常对照者。5 至 17 岁的儿童完成了儿童 PedEyeQ(5-11 岁和 12-17 岁版本),家长完成了代理 PedEyeQ(0-4 岁、5-11 岁和 12-17 岁版本)和家长 PedEyeQ。根据每个年龄特异性 PedEyeQ 中的每个不同领域,按年龄组计算 Rasch 分数(转换为 0-100 进行解释)。儿童 PedEyeQ 的领域包括功能性视力、眼睛/视力困扰、社会和挫折/担忧。代理 PedEyeQ 领域包括功能性视力、眼睛/视力困扰、社会、挫折/担忧和眼部护理。家长 PedEyeQ 领域包括对家长和家庭的影响、对孩子眼部状况的担忧、对孩子自我认知/互动的担忧以及对孩子功能性视力的担忧。对于每个领域,比较视力障碍和视力正常组之间的中位数 PedEyeQ 评分。
儿童 5-11 岁和 12-17 岁的 PedEyeQ 评分在各个领域(除了 5-11 岁儿童的社会领域,P=0.13),视力障碍儿童均显著低于(更差)对照组。此外,在所有领域中,代理 0-4 岁、5-11 岁和 12-17 岁的 PedEyeQ 评分和家长 PedEyeQ 评分均低于视力障碍儿童(P<0.001)。
视力障碍儿童及其家长的 PedEyeQ 评分明显低于(更差)视力正常对照组,在功能性视力和眼部相关生活质量领域,表明 PedEyeQ 在视力障碍儿童中的具有已知组有效性。